SNM experts focus on advances in molecular imaging for cancer, addiction, Alzheimer's, heart disease

January 30, 2006

Leading medical investigators will present recent developments in the diagnosis of cancer and heart and brain diseases during the Society of Nuclear Medicine's Mid-Winter Educational Symposium Feb. 11-12 at Wyndham Buttes in Tempe, Ariz.

Noted physicians, scientists and technologists will present the latest news about using nuclear medicine and molecular imaging for the diagnosis, management and treatment of diseases to several hundred nuclear medicine physicians, radiologists, cardiologists, oncologists, technologists, pharmacists, medical physicists and other health care professionals. SNM is the largest scientific organization dedicated to nuclear medicine and molecular imaging, with more than 16,000 members. This year's topics include new molecular imaging agents for oncology, new developments in Alzheimer's disease and addiction, an overview of congestive heart failure and nuclear imaging, imaging atherosclerosis and stem cells, radiation safety, potential future clinical tracers, an introduction to cell and molecular biology, small animal imaging instrumentation and the evolving role of a nuclear medicine technologist.

"The society offers an exciting two-day program in Tempe exploring the development of novel probes in molecular imaging, monitoring treatment response with positron emission tomography, radiotracer imaging in congestive heart failure, advanced image processing and clinical nuclear medicine technology," said SNM President Peter S. Conti, M.D., Ph.D., professor of radiology, clinical pharmacy and biomedical engineering at the University of Southern California, Los Angeles. "In addition, the evolving role of nuclear medicine technologists will be examined," added SNM Technologist Section (SNMTS) President Valerie R. Cronin, CNMT, FSNMTS, director of imaging services at the Catholic Health System of Western New York in Buffalo, N.Y.
-end-
For more information or to register, visit SNM's Web site: http://www.snm.org/mwm.

About the Society of Nuclear Medicine
The Society of Nuclear Medicine is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of nuclear medicine and molecular imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances; provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed resource in the field of nuclear and molecular imaging: The Journal of Nuclear Medicine; sponsor research grants, fellowships and awards; and host the premier nuclear medicine annual meeting. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.

Society of Nuclear Medicine

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.